Skip to content

Clinical trials

Hepatoblastoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatoblastoma Clear all

81 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20042
20052
20061
20071
20081
20091
20101
20116
20131
20142
20152
20162
20179
20188
20191
20205
202110
20227
20232
20242
20255

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Active, not recruiting16
Recruiting15
Unknown status9
Terminated4
Withdrawn4
No longer available1
Available1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)16
Children's Oncology Group9
Emory University4
Masonic Cancer Center, University of Minnesota3
Memorial Sloan Kettering Cancer Center3
Seattle Children's Hospital3
Baylor College of Medicine2
Children's Hospital Medical Center, Cincinnati2
RenJi Hospital2
Shanghai Children's Medical Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatoblastoma81
Neuroblastoma45
Wilms Tumor38
Rhabdomyosarcoma35
Osteosarcoma33
Sarcoma33
Sarcoma, Ewing28
Medulloblastoma27
Rhabdoid Tumor26
Neuroectodermal Tumors, Primitive, Peripheral21

Trials

Showing 26 to 50 of 81. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.